Unique ID issued by UMIN | UMIN000040688 |
---|---|
Receipt number | R000046378 |
Scientific Title | Prolonged versus Intermittent beta-lactam Antibiotics Intravenous Infusion Strategy in Sepsis or Septic Shock: A Systematic Review and Meta-Analysis of Randomized Trials. |
Date of disclosure of the study information | 2020/06/08 |
Last modified on | 2020/06/08 13:35:35 |
Prolonged versus Intermittent beta-lactam Antibiotics Intravenous Infusion Strategy in Sepsis or Septic Shock: A Systematic Review and Meta-Analysis of Randomized Trials.
Prolonged versus Intermittent beta-lactam Antibiotics Intravenous Infusion Strategy in Sepsis or Septic Shock: A Systematic Review and Meta-Analysis of Randomized Trials.
Prolonged versus Intermittent beta-lactam Antibiotics Intravenous Infusion Strategy in Sepsis or Septic Shock: A Systematic Review and Meta-Analysis of Randomized Trials.
Prolonged versus Intermittent beta-lactam Antibiotics Intravenous Infusion Strategy in Sepsis or Septic Shock: A Systematic Review and Meta-Analysis of Randomized Trials.
Japan |
Sepsis or septic shock
Infectious disease | Emergency medicine | Intensive care medicine |
Others
NO
The aim of this study is to conduct systematic review and meta-analysis of the present randomized controlled trials (RCTs) to assess the efficacy of prolonged versus intermittent beta-lactam antibiotics infusion strategy on outcomes in sepsis or septic shock patients.
Efficacy
hospital mortality
attainment of target plasma concentration, clinical cure, adverse event, and occurrence of antibiotic-resistant bacteria
Others,meta-analysis etc
18 | years-old | <= |
Not applicable |
Male and Female
We identified studies to be included by following the research question formulated according to the participants, interventions, comparisons and outcomes (PICO) model as follows: P, adult (>=18 years of age) patients admitted to the ICU with a diagnosis of sepsis or septic shock; I, prolonged beta-lactam antibiotics infusion strategy (continuous or extended time [more than 1 hour but not continuous] of intravenous infusion); C, intermittent beta-lactam antibiotics infusion strategy (within 1 hour of intravenous infusion); O, All-cause mortality.
Under 18 years-old
1st name | Yutaka |
Middle name | |
Last name | Kondo |
Juntendo University Urayasu Hospital
Department of Emergency and Critical Care Medicine
279-0021
2-1-1, Tomioka, Urayasu, Chiba, Japan
047-353-3111
kondokondou2000@yahoo.co.jp
1st name | Yutaka |
Middle name | |
Last name | Kondo |
Juntendo University Urayasu Hospital
Department of Emergency and Critical Care Medicine
279-0021
2-1-1, Tomioka, Urayasu, Chiba, Japan
047-353-3111
kondokondou2000@yahoo.co.jp
Juntendo University Urayasu Hospital
Self funding
Self funding
Juntendo University Urayasu Hospital
Department of Emergency and Critical Care Medicine
047-353-3111
kondokondou2000@yahoo.co.jp
NO
2020 | Year | 06 | Month | 08 | Day |
Unpublished
825
Completed
2019 | Year | 04 | Month | 27 | Day |
2019 | Year | 04 | Month | 27 | Day |
2019 | Year | 04 | Month | 27 | Day |
2020 | Year | 06 | Month | 01 | Day |
<Search method>
Electronic detabases were used below.
1. the Cochrane Central Register of Controlled Trials(CENTRAL)
2. MEDLINE
3. Igaku Chuo Zasshi (ICHUSHI) Web
<Analysis>
Meta-analysis will be performed using the Review Manger, Cochrane systematic review software, version 5.3.5 for Windows.
2020 | Year | 06 | Month | 08 | Day |
2020 | Year | 06 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046378